10.02.2013 Views

Singapore SME Innovation Support Schemes - PRO INNO Europe

Singapore SME Innovation Support Schemes - PRO INNO Europe

Singapore SME Innovation Support Schemes - PRO INNO Europe

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

od of 3 to 12 months. Companies are given the option to license the technology if the<br />

development project is successful. Essentially Exploit is taking the risk of proving the<br />

technology to a commercial ready state. This can be particularly beneficial if the potential<br />

licensees are <strong>SME</strong>s as they are generally not ready to take on the commercialisation<br />

of a technology unless it is proven.<br />

Exploit also operates a business incubation process, which attempts to identify new<br />

technologies at an early stage in the research and direct the development of these with<br />

commercialisation firmly in mind. These are likely to be technologies which can have<br />

multiple and cross-disciplinary applications and have the potential to grow into new<br />

industrial sectors. These are referred to as flagship projects and Exploit can provide<br />

S$3 – 5 million (€1.8 - 3milliom) to fund the business incubation of these technologies.<br />

Researchers can submit a proposal to Exploit for this flagship funding.<br />

Exploit also work closely with large multinational companies to translate technologies<br />

into application, through a research collaboration agreement. In this case the company<br />

would license the technology from A*Star. Exploit maintains and advertises (through<br />

Tech Alerts and RSS feeds) a database of A*Star technologies which are ready for commercialisation.<br />

Exploit has a standard license agreement which it provides online, and licensing agreements<br />

can be concluded in a matter of weeks if companies agree to these standard<br />

terms. Exclusive or non-exclusive licenses can be granted, however exclusive licenses<br />

might only be granted in cases where technology requires substantial development, or<br />

investment. Exclusive licenses might typically be restricted to specific fields of use, geographic<br />

areas, and/or time periods. The right to further develop the technology is usually<br />

retained by Exploit and typically there is no exclusive access granted to any further<br />

future A*Star developments of the technology.<br />

Exploit looks at the IP portfolio and examines it for commercial opportunities. In doing<br />

this it doesn’t have a particular bias towards the creation of spin-outs or serving <strong>SME</strong>s as<br />

opposed to large companies as it needs to be aware of its mission to serve all industry<br />

through the licensing of IP. Licensing seems to be the more usual route for commercial<br />

exploitation, with spin-offs being the more unusual. Licensing terms to industry are generally<br />

flexible. In terms of the number of licenses more go to <strong>SME</strong>s than large companies,<br />

however in terms of the value of licenses large companies account for the greatest share.<br />

Licensing is looked at in a flexible manner where the goal is very much financial benefit<br />

to <strong>Singapore</strong> as opposed to benefit to any one research institute or organisation and Exploit<br />

would be conscious that there must be a balance struck in this regard.<br />

Exploit currently manages a portfolio of over 3000 active patents, have granted over<br />

250 licenses, and have a portfolio of 24 spin-off companies. The estimated business revenues<br />

arising from the A*Star licensed technologies is S$500 million (€300 million). The<br />

total market value created though A*Star start-ups amounts to more than S$100 million<br />

(€60 million).<br />

PAGE 22<br />

www.proinno-europe.eu/partnering-forum

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!